Puma Biotechnology Inc (NYSE:PBYI)
| 37.53 Data as of May 20 |  +0.17 / +0.46%Today’s Change | 11.00 Today|||52-Week Range 39.34 | +100.16% Year-to-Date |
Latest PBYI News | Press Releases
| 5 Stocks Rising on Unusual Volume May 20 / TheStreet.com |
Today’s Trading
| Previous close | 37.36 |
| Today’s open | 37.11 |
| Day’s range | -- - -- |
| Volume | 179,277 |
| Average volume (3 months) | 132,032 |
| Market cap | $1.1B |
| Dividend yield | -- |
Data as of 4:02pm ET, 05/20/2013
Growth & Valuation
| Earnings growth (last year) | -158.89% |
| Earnings growth (this year) | +32.23% |
| Earnings growth (next 5 years) | -21.67% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 8.35 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PDLIPDL BioPharma Inc | -0.01 | -0.12% |
| TSROTESARO Inc | -0.41 | -1.14% |
| SRPTSarepta Therapeutics... | +0.22 | +0.60% |
| CLVSClovis Oncology Inc | -1.29 | -3.49% |
Data as of 4:00pm ET, 05/20/2013
Financials
| Next reporting date | August 14, 2013 |
| EPS forecast (this quarter) | -$0.62 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$74.4M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
Chairman, President & Chief Executive Officer Alan H. Auerbach |
Treasurer & Senior Vice President-Administration Charles R. Eyler, MBA |
Corporate headquarters Los Angeles, California |
Forecasts
